In nine patients with atrial fibrillation (AF) of <3 months' duration, CBF was measured the day before and after and again 30 days after electrical cardioversion therapy to sinus rhythm. The day before cardioversion therapy, median CBF (expressed as initial slope index 1, ml/lOO g . min -I ) was 35.8 and the day after it was 37.1.
Cerebrovascular complications in atrial fibrilla tion (AF) are often due to embolism (Wolf et aI., 1978) . Recent studies have suggested that other fac tors than embolism may be of importance in the development of cerebral complications in AF (Lavy et aI., 1980; Yamauchi et aI., 1986; Gustafsson et aI., 1987) . In one study CBF was reduced in pa tients with chronic AF compared with controls in sinus rhythm (Lavy et aI., 1980) . The purpose of the present study was to determine the CBF in patients with chronic AF of short duration before and after electrical cardioversion to sinus rhythm.
METHODS
Thirteen patients (10 men and 3 women) with AF ad mitted to the Department of Cardiology for electrical car dioversion therapy during 1987 were included in the study. Nine men completed the entire study (median age 61 years, range 24-63 years); in four patients cardiover sion therapy was without success. The AF had been di-treatment values. After correction for changes in end tidal Pc02, the median CBF had increased significantly from 35.8 to 40.3 on day 1 and to 46.7 on day 30. The reduced CBF during AF could be a contributing factor in the development of cerebrovascular complications in pa tients with AF. Key Words: Atrial fibrillation-Cerebral blood flow. agnosed 1-3 months before admission. Before inclusion into the study, all patients were examined by a cardiolo gist with echocardiography. The laboratory tests included examination of thyroid status and chest radiograph. Of the nine patients who underwent successful cardiover sion, seven had idiopathic AF and two had congestive cardiomyopathy. No patients had systemic hypertension, congestive heart failure, or chronic renal failure and all were without a history of head injury and cerebrovascular disease. As anesthesia during cardioversion therapy di azepam and thiopental were used. The patients were on constant oral medication with digoxin during the entire study period, and within 4 weeks before and after the study several analyses showed serum digoxin within the therapeutic range. CBF, echocardiography, cardiac out put, electrocardiogram, systemic blood pressure, and heart rate were measured the day before and after the cardioversion therapy during hospitalization and again in the outpatient clinic after 30 days. CBF was measured by the intravenous xenon-133 tech nique as described previously (Thomas et al., 1979; Kas trup et al., 1986) . A bolus of xenon-133, 10-15 mCi (370-555 MBq), dissolved in isotonic saline was injected into a vein on the dorsum of the hand and the cannula was then flushed with isotonic saline for 20 s. Five sodium iodide detectors placed at each side of the head covering the temporal and central aspects of each hemisphere mea sured the clearance of the isotope by a Cerebrograph lOA (Novo Diagnostic System, Hadsund, Denmark) . From a tightly fitted face mask, air samples were drawn contino uously for estimation of arterial recirculation of xenon· 133 and for end-tidal Pc02 determination measured witt an infrared absorbance method (Capnograph CK 101; Datex, Helsinki, Finland). CBF was calculated for each of the 10 detectors after correcting for air passage. CBF was expressed by the initial slope index as described by Risberg et al. (1975) . The blood flow in the entire brain was calculated as the mean value of the 10 CBF readings.
During the investigation the patients were placed in the supine position in a quiet room. After 30 min at rest, the CBF was measured twice within 1 h except on four oc casions where CBF due to technical reasons was mea sured only once. The first measurement was used for sta tistical analysis of differences between pre-and posttreat ment values of CBF. The second measurement was used for reproducibility analysis, but not for analysis of varia tions between the first and second measurements owing to the four missing second measurements. CBF was cor rected by 2% for each millimeter of mercury (0.13 kPa) change in end-tidal Pco2 (Maximilian et aI., 1980) . The first Pco2 value obtained before cardioversion was used for correction. Cardiac output was determined with a noninvasive Doppler technique as described by Hunts man et al. (1983) .
Owing to the small number of patients, all tests of hy potheses will have a low power and consequently only strong variations across time will be detected. Without imposing assumptions concerning distributions and struc ture of the data, we may, however, consider one obvious consequence of the hypothesis of no differences between the measurements. Classifying the three measurements of a given patient as, respectively, "high," "medium" and "low," it gives six different patterns of measurements, each with a probability of one-sixth if only random dif ferences occur. Calculating the frequency of different pat terns (disregarding the few cases with ties), the signifi cance may be evaluated exactly by the cumulative prob abilities of the multi nominal distribution (Tate-Clelland's test). Additionally, Friedman's two-way analysis of vari ance was used to assess the overall significance of changes with time. Both tests are of relatively low power for which reason significant evidence against the hypoth esis becomes even more convincing. Only p values of <0.05 were considered significant.
RESULTS
All patients had normal hemoglobin and serum concentrations of sodium, potassium, and creati nine. The changes in mean arterial blood pressure and heart rate were not statistically significant (Ta ble O. There was no statistical difference between the first and the second CBF measurement per formed on the same day. The day before the car dioversion therapy, the median (range) CBF was 35.8 (24.1-44. 1) and the day after it was 37.1 (31.9-52.7). After 30 days, seven patients had increased CBF despite significantly lower values of end-tidal Pco2 with a median (range) CBF for all nine patients of 39.4 (29.1-55.7) (NS). After correction for changes in Pco2, the median (range) CBF increased significantly from 35.8 (24. 1-44. 1) to 40.3 (30.9-54.9) on day 1 and to 46.7 (29.9-54.3) after 30 days in sinus rhythm (p = 0.009, Tate-Clelland's test; p = 0.018, Friedman's test) ( Table 1) . Cardiac output in eight patients was unchanged with median (range) values of 6.4 (5.3-8.3),6.8 (5.4-8.7), and 6.6 (5.4-8.5) Llmin before, the day after, and after 30 days, respectively. Because of technical reasons, cardiac output could not be determined in one pa tient.
DISCUSSION
Emboli from the heart are usually considered the cause of the cerebrovascular complications in pa tients with AF. Studies on risk factors for stroke occurrence in AF, including systemic hypertension, coronary artery disease, degree of heart failure, and thyrotoxicosis, have shown conflicting results (Wolf et aI., 1983; Flegel et aI., 1987; Petersen and Godtfredsen, 1988) . However, other factors might play a role, such as changes in coagulation param eters and changes in CBF. Left atrial dimension and atrial natriuretic peptide (ANP) might also influence the stroke risk in AF (Petersen and Godtfredsen, 1988) .
Before cardioversion the median CBF was below normal values with this method, but similar to the level found in atherosclerotic patients of the same age (Schroeder et aI., 1986) . Mter conversion of AF All values are medians (range) . lSI, initial slope index .
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to sinus rhythm, a significant increase in CBF from 35.8 to 46. 7 was demonstrated. In young healthy subjects, the CBF with this method was �50, and, considering a decline in CBF with age of �10% from 30 to 60 years, the CBF after 30 days was within normal limits (Schroeder et aI., 1986) . It is debatable whether CBF should be corrected for changes in end-tidal Peo2• It is well known that acute changes in Peo2 may influence CBF (Shapiro et aI., 1965) and that CBF tends to adapt during chronic hypo-and hypercapnia (Skinhji)j, 1968). De spite a decrease in Peo2 30 days after the cardio version therapy, seven of the nine patients had in creased CBF values. This was not statistically sig nificant probably owing to the small number of patients studied. We have no explanation of the lower Peo2 values obtained 30 days after the car dioversion therapy. The patients were familiar with the applied technique and there seemed to be no obvious reason for hyperventilation except that the first two measurements were obtained during hos pitalization and the third as outpatients. On the other hand, it is unlikely that patients 30 days after cardioversion of AF should have a permanent de crease of Peo2• It seems most likely that the change in Peo2 was a transient phenomenon. It was there fore judged permissible to correct CBF for the change in Peo2.
The results of the present study are in accordance with those from a study by Lavy et ai. (1980) , who found a reduction in CBF of l3% in patients with chronic AF between 51 and 65 years of age com pared with a control group in sinus rhythm. The cause of the low CBF in the present patients with AF is unknown. Since CBF normalized after car dioversion to sinus rhythm, cerebral atherosclerosis seems not to be a plausible explanation of the low CBF. The blood pressure was normal and constant both before and after cardioversion therapy and cardiac output was unchanged during the study pe riod. Patients with severe heart failure may have decreased CBF (Rajagopalan et aI., 1984; Paulson et aI., 1986) , but this explanation could not be ac counted for in the present study where none of the patients had heart failure.
It has recently been shown that the plasma con centration of ANP is increased in patients with AF and that it normalizes after obtainment of sinus rhythm (Anderson et aI., 1986; Grozier et aI., 1987; Roy et aI., 1987) , and the same result was obtained in the eight patients studied in this series (Petersen et aI., 1988) . In rats injection of ANP increases the hematocrit (de Bold et aI., 198 1; Fliickiger et aI., 1986) , and in humans increased hematocrit de creases the CBF (Massik et aI., 1987) . Patients with paroxysmal AF have higher hematocrit during par oxysms than during sinus rhythm (Imataka et aI., 1987) . The hematocrit was not measured in the present study. The hemoglobin measured before cardioversion was within normal limits, and since cardiac output was unchanged after cardioversion, it is not likely that a significant change in hematocrit had taken place. Accordingly, the changes in CBF seem not to be due to changes in hematocrit. Chabrier et ai. (1987) found ANP receptors in the microvessels in the brain. However, whether ANP actually influences CBF is at present unknown. A possible causal relationship between ANP, CBF, and cerebrovascular complications in AF would agree with clinical studies showing a low incidence of stroke in patients with paroxysmal AF compared with patients with chronic AF (Petersen and Godt fredsen, 1986; Treseder et aI., 1986) .
In summary, CBF was reduced in patients with AF without heart failure and increased after electri cal cardioversion therapy to sinus rhythm. This im plies that reduced CBF may contribute to the fre quent cerebral complications in AF.
